Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 9, 2013 - Issue 12
Submit an article Journal homepage
533
Views
11
CrossRef citations to date
0
Altmetric
Commentary

Generation of more effective cancer vaccines

Daniela Fenoglio Centre of Excellence for Biomedical Research; University of Genoa; Genoa, Italy; Department of Internal Medicine; University of Genoa; Genoa, Italy
,
Paolo Traverso Centre of Excellence for Biomedical Research; University of Genoa; Genoa, Italy; Department of Surgical Sciences; University of Genoa; Genoa, Italy
,
Alessia Parodi Centre of Excellence for Biomedical Research; University of Genoa; Genoa, Italy
,
Francesca Kalli Centre of Excellence for Biomedical Research; University of Genoa; Genoa, Italy
,
Maurizio Zanetti The Laboratory of Immunology; Department of Medicine and Cancer Center; University of California; San Diego, CA USA
&
Gilberto Filaci Centre of Excellence for Biomedical Research; University of Genoa; Genoa, Italy; Department of Internal Medicine; University of Genoa; Genoa, ItalyCorrespondence[email protected]
Pages 2543-2547 | Received 21 Jul 2013, Accepted 14 Aug 2013, Published online: 26 Aug 2013

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Amin Kamrani, Amir Mehdizadeh, Majid Ahmadi, Leili Aghebati-Maleki & Mehdi Yousefi. (2019) Therapeutic approaches for targeting receptor tyrosine kinase like orphan receptor-1 in cancer cells. Expert Opinion on Therapeutic Targets 23:5, pages 447-456.
Read now
Mostafa Haji-Fatahaliha, Maryam Hosseini, Asiye Akbarian, Sanam Sadreddini, Farhad Jadidi-Niaragh & Mehdi Yousefi. (2016) CAR-modified T-cell therapy for cancer: an updated review. Artificial Cells, Nanomedicine, and Biotechnology 44:6, pages 1339-1349.
Read now

Articles from other publishers (9)

Mona Kamal Saadeldin, Amal Kamal Abdel-Aziz & Ahmed Abdellatif. (2021) Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis. Medical Hypotheses 146, pages 110365.
Crossref
Simone Negrini, Raffaele De Palma & Gilberto Filaci. (2020) Anti-Cancer Immunotherapies Targeting Telomerase. Cancers 12:8, pages 2260.
Crossref
Fabio Barra, Luigi Della Corte, Giovanni Noberasco, Virginia Foreste, Gaetano Riemma, Claudia Di Filippo, Giuseppe Bifulco, Andrea Orsi, Giancarlo Icardi & Simone Ferrero. (2020) Advances in therapeutic vaccines for treating human papillomavirus‐related cervical intraepithelial neoplasia. Journal of Obstetrics and Gynaecology Research 46:7, pages 989-1006.
Crossref
Sean K. Maynard, Jason D. Marshall, Randall S. MacGill, Li Yu, Jennifer A. Cann, Lily I. Cheng, Michael P. McCarthy, Corinne Cayatte & Scott H. Robbins. (2019) Vaccination with synthetic long peptide formulated with CpG in an oil-in-water emulsion induces robust E7-specific CD8 T cell responses and TC-1 tumor eradication. BMC Cancer 19:1.
Crossref
Juha‐Pekka Mattila, Leonardo Mirandola & Maurizio Chiriva‐Internati. (2018) Development of a M cell‐targeted microparticulate platform, BSK02™, for oral immunization against the ovarian cancer antigen, sperm protein 17. Journal of Biomedical Materials Research Part B: Applied Biomaterials 107:1, pages 29-36.
Crossref
Anagha Bangalore Kumar, Rachel Maus & Svetomir N. Markovic. (2018) Pharmacologic Modulation of Human Immunity in the Era of Immuno-oncology: Something Old, Something New. Mayo Clinic Proceedings 93:7, pages 917-936.
Crossref
Sofia Farkona, Eleftherios P. Diamandis & Ivan M. Blasutig. (2016) Cancer immunotherapy: the beginning of the end of cancer?. BMC Medicine 14:1.
Crossref
Stefano Ugel, John G. Facciponte, Francesco De Sanctis & Andrea Facciabene. (2015) Targeting tumor vasculature: expanding the potential of DNA cancer vaccines. Cancer Immunology, Immunotherapy 64:10, pages 1339-1348.
Crossref
Alessandro Poggi, Alessandra Musso, Irene Dapino & Maria Raffaella Zocchi. (2014) Mechanisms of tumor escape from immune system: Role of mesenchymal stromal cells. Immunology Letters 159:1-2, pages 55-72.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.